In parallel, OVs can disrupt the cytoskeleton architecture of tumor cells by modulating signaling pathways such as Rho/ROCK and PI3K/Akt/mTOR, which regulate cytoskeletal dynamics. The gene discussed is AKT1; the disease is neoplasm.